On Wednesday of this week the Senate Finance Committee put forth the Prescription Drug Pricing Act of 2019. The Lymphedema Treatment Act was one of a number of other provisions then added as amendments! On Thursday, some of the amendments, particularly those not related to drug pricing, were withdrawn by the sponsors of those […]
From the category archives: